Found: 10
Select item for more details and to access through your institution.
Prognostic signatures and potential pathogenesis of eRNAs‐related genes in colon adenocarcinoma.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 1, p. 59, doi. 10.1002/mc.23359
- By:
- Publication type:
- Article
Rapalogs induce non‐apoptotic, autophagy‐dependent cell death in HPV‐negative TP53 mutant head and neck squamous cell carcinoma.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 1, p. 33, doi. 10.1002/mc.23357
- By:
- Publication type:
- Article
Low expression of lncRNA SBF2‐AS1 regulates the miR‐302b‐3p/TGFBR2 axis, promoting metastasis in laryngeal cancer.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 1, p. 45, doi. 10.1002/mc.23358
- By:
- Publication type:
- Article
Triterpenoid ursolic acid drives metabolic rewiring and epigenetic reprogramming in treatment/prevention of human prostate cancer.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 1, p. 111, doi. 10.1002/mc.23365
- By:
- Publication type:
- Article
Transcriptional repression of E‐cadherin in nickel‐exposed lung epithelial cells mediated by loss of Sp1 binding at the promoter.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 1, p. 99, doi. 10.1002/mc.23364
- By:
- Publication type:
- Article
PARP5B is required for nonhomologous end joining during tumorigenesis in vivo.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 1, p. 85, doi. 10.1002/mc.23363
- By:
- Publication type:
- Article
Nuclear receptor 4A1 (NR4A1) antagonists target paraspeckle component 1 (PSPC1) in cancer cells.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 1, p. 73, doi. 10.1002/mc.23362
- By:
- Publication type:
- Article
Sulforaphane covalently interacts with the transglutaminase 2 cancer maintenance protein to alter its structure and suppress its activity.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 1, p. 19, doi. 10.1002/mc.23356
- By:
- Publication type:
- Article
Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladder.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 1, p. 5, doi. 10.1002/mc.23355
- By:
- Publication type:
- Article
Issue Information ‐ Ed Board.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 1, p. 1, doi. 10.1002/mc.23311
- Publication type:
- Article